C

Cyclacel Pharmaceuticals
D

CYCC

15.990
USD
-0.76
(-4.54%)
مغلق
حجم التداول
10,987
الربح لكل سهم
-1
العائد الربحي
-
P/E
0
حجم السوق
25,327,600
أصول ذات صلة
A
ARAY
-0.00500
(-0.37%)
1.36500 USD
A
AXSM
-4.200
(-4.00%)
100.830 USD
C
CRBP
0.18000
(2.00%)
9.17000 USD
C
CYCCP
-0.62000
(-11.05%)
4.99000 USD
J
JAGX
-0.06000
(-2.62%)
2.23000 USD
K
KZIA
-0.03000
(-0.30%)
9.91000 USD
P
PAVM
-0.00980
(-1.63%)
0.59000 USD
V
VKTX
0.960
(2.87%)
34.420 USD
المزيد
الأخبار المقالات

العنوان: Cyclacel Pharmaceuticals Inc

القطاع: Healthcare
الصناعة: Biotechnology
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.